Fibrinogen α and γ genes and factor VLeiden in children with thromboembolism: Results from 2 family-based association studies

Blood

Volumn 114, Issue 9, 2009, Pages 1947-1953

  Nowak Gött, Ulrike ^a   Weiler, Hartmut ^b   Hernandez, Irene ^b   Thedieck, Sabine ^a   Seehafer, Tanja ^a   Schulte, Thomas ^a   Stoll, Monika ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOGEN; FIBRINOGEN ALPHA; FIBRINOGEN GAMMA; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR 5; FIBRINOGEN AALPHA; FIBRINOGEN GAMMA'; FIBRINOGEN VARIANT;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FIBRINOGEN BLOOD LEVEL; GENE INTERACTION; GENE MUTATION; GENETIC RISK; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE; THROMBOEMBOLISM; THROMBOSIS; CASE CONTROL STUDY; COHORT ANALYSIS; FAMILY HEALTH; GENETICS; INFANT; PRESCHOOL CHILD; VEIN THROMBOSIS;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FACTOR V; FAMILY HEALTH; FEMALE; FIBRINOGEN; FIBRINOGENS, ABNORMAL; HUMANS; INFANT; MALE; THROMBOEMBOLISM; THROMBOSIS; VENOUS THROMBOSIS;

EID: 70349249995     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-04-218727     Document Type: Article

References (34)

1. Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briet E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis: a case-control study of plasma levels and DNA polymorphisms - the Leiden Thrombophilia Study (LETS). Thromb Haemost. 1994;71:719-722.
2. Van Hylckama Vlieg A, Callas PW, Cushman M, Bertina RM, Rosendaal FR. Inter-relation of coagulation factors and d-dimer levels in healthy individuals. J Thromb Haemost. 2003;1:516-522.
3. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood. 2000;95:1517-1532.
4. Kardys I, Uitterlinden AG, Hofman A, Witteman JC, de Maat MP. Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: the Rotterdam Study. Thromb Haemost. 2007;97:288-295. (Pubitemid 46592150)
5. Uitte de Willige S, de Visser MC, Houwing-Duistermaat JJ, Rosendaal FR, Vos HL, Bertina RM. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma′ levels. Blood. 2005;106:4176-4183.
6. Grünbacher G, Weger W, Marx-Neuhold E, et al. The fibrinogen gamma (FGG) 10034CT polymorphism is associated with venous thrombosis. Thromb Res. 2007;121:33-36. (Pubitemid 350026004)
7. Young G, Albisetti M, Bonduel M, et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation. 2008;118:1373-1382.
8. Nowak-Göttl U, Kurnik K, Krumpel A, Stoll M. Thrombophilia in the young. Hamostaseologie. 2008;28:16-20.
9. Caruso V, Iacoviello L, Di Castelnuovo A, et al. Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood. 2006;108:2216-2222. (Pubitemid 44497502)
10. Haywood S, Liesner R, Pindora S, Ganesan V. Thrombophilia and first arterial ischaemic stroke: a systematic review. Arch Dis Child. 2005;90:402-405. (Pubitemid 40488681)
11. Sträter R, Becker S, von Eckardstein A, et al. Prospective assessment of risk factors for recurrent stroke during childhood: a 5-year follow-up study. Lancet. 2002;360:1540-1545. (Pubitemid 35356368)
12. Nowak-Göttl U, Langer C, Bergs S, Thedieck S, Strater R, Stoll M. Genetics of hemostasis: differential effects of heritability and household components influencing lipid concentrations and clotting factor levels in 282 pediatric stroke families. Environ Health Perspect. 2008;116:839-843. (Pubitemid 351943943)
13. Mosesson MW, Hernandez I, Raife TJ, et al. Plasma fibrinogen gamma′ chain content in the thrombotic microangiopathy syndrome. J Thromb Haemost. 2007;5:62-69. (Pubitemid 44921068)
14. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265. (Pubitemid 40202029)
15. Junker R, Koch HG, Auberger K, Munchow N, Ehrenforth S, Nowak-Gottl U. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol. 1999;19:2568-2572. (Pubitemid 29477861)
16. Nowak-Göttl U, Sträter R, Heinecke A, et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999;94:3678-3682.
17. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993;52:506-516. (Pubitemid 23311321)
18. Jood K, Danielson J, Ladenvall C, Blomstrand C, Jern C. Fibrinogen gene variation and ischemic stroke. J Thromb Haemost. 2008;6:897-904. (Pubitemid 351689909)
19. Carter AM, Catto AJ, Kohler HP, Ariens RA, Stickland MH, Grant PJ. alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood. 2000;96:1177-1179. (Pubitemid 30616891)
20. Cheung EY, Uitte de Willige S, Vos HL, et al. Fibrinogen gamma′ in ischemic stroke: a case-control study. Stroke. 2008;39:1033-1035. (Pubitemid 351619556)
21. Rasmussen-Torvik LJ, Cushman M, Tsai MY, et al. The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study. Thromb Res. 2007;121:1-7. (Pubitemid 350025992)
22. Le Gal G, Delahousse B, Lacut K, et al. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism. Thromb Res. 2007;121:333-338.
23. Carter AM, Catto AJ, Grant PJ. Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. Circulation. 1999;99:2423-2426.
24. Standeven KF, Grant PJ, Carter AM, Scheiner T, Weisel JW, Ariens RA. Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function. Circulation. 2003;107:2326-2330. (Pubitemid 36578503)
25. Mosesson MW, Cooley BC, Hernandez I, Diorio JP, Weiler H. Thrombosis risk modification in transgenic mice containing the human fibrinogen thrombin-binding gamma′ chain sequence. J Thromb Haemost. 2009;7:102-110.
26. Falls LA, Farrell DH. Resistance of gammaA/gamma′ fibrin clots to fibrinolysis. J Biol Chem. 1997;272:14251-14256.
27. Lovely RS, Moaddel M, Farrell DH. Fibrinogen gamma′ chain binds thrombin exosite II. J Thromb Haemost. 2003;1:124-131.
28. Fredenburgh JC, Stafford AR, Leslie BA, Weitz JI. Bivalent binding to gammaA/gamma′-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex. J Biol Chem. 2008;283:2470-2477.
29. Ariens RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood. 2002;100:743-754.
30. Mosesson MW. Update on antithrombin I (fibrin). Thromb Haemost. 2007;98:105-108.
31. Campbell RA, Overmyer KA, Bagnell CR, Wolberg AS. Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface. Arterioscler Thromb Vasc Biol. 2008;28:2247-2254.
32. Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev. 2007;21:131-142. (Pubitemid 46541695)
33. Wolberg AS, Allen GA, Monroe DM, Hedner U, Roberts HR, Hoffman M. High dose factor VIIa improves clot structure and stability in a model of haemophilia B. Br J Haematol. 2005;131:645-655. (Pubitemid 43899632)
34. Wolberg AS, Monroe DM, Roberts HR, Hoffman M. Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood. 2003;1001:3008-3013. (Pubitemid 36857988)